572 related articles for article (PubMed ID: 25659895)
1. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
2. Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.
Izenberg JM; Bachireddy C; Wickersham JA; Soule M; Kiriazova T; Dvoriak S; Altice FL
Int J Drug Policy; 2014 Sep; 25(5):845-52. PubMed ID: 24951025
[TBL] [Abstract][Full Text] [Related]
3. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
Chakrapani V; Kamei R; Kipgen H; Kh JK
Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
[TBL] [Abstract][Full Text] [Related]
4. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.
Bachireddy C; Bazazi AR; Kavasery R; Govindasamy S; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2011 Jul; 116(1-3):151-7. PubMed ID: 21232882
[TBL] [Abstract][Full Text] [Related]
5. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
[TBL] [Abstract][Full Text] [Related]
6. Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.
Sawitri AA; Hartawan AA; Craine N; Sari AK; Septarini NW; Wirawan DN
Int J Prison Health; 2016; 12(1):27-38. PubMed ID: 26933990
[TBL] [Abstract][Full Text] [Related]
7. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
[TBL] [Abstract][Full Text] [Related]
8. Behavioural change amongst drug injectors in Scottish prisons.
Shewan D; Gemmell M; Davies JB
Soc Sci Med; 1994 Dec; 39(11):1585-6. PubMed ID: 7817222
[TBL] [Abstract][Full Text] [Related]
9. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
[TBL] [Abstract][Full Text] [Related]
10. People who inject drugs in prison: HIV prevalence, transmission and prevention.
Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
[TBL] [Abstract][Full Text] [Related]
11. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.
Azbel L; Polonsky M; Wegman M; Shumskaya N; Kurmanalieva A; Asanov A; Wickersham JA; Dvoriak S; Altice FL
Int J Drug Policy; 2016 Nov; 37():9-20. PubMed ID: 27455177
[TBL] [Abstract][Full Text] [Related]
12. HIV risk behaviour correlates among injecting drug users in Greek prisons.
Koulierakis G; Gnardellis C; Agrafiotis D; Power KG
Addiction; 2000 Aug; 95(8):1207-16. PubMed ID: 11092068
[TBL] [Abstract][Full Text] [Related]
13. Drug use and injection risk-taking among prison methadone maintenance patients.
Darke S; Kaye S; Finlay-Jones R
Addiction; 1998 Aug; 93(8):1169-75. PubMed ID: 9813898
[TBL] [Abstract][Full Text] [Related]
14. Pre-incarceration police harassment, drug addiction and HIV risk behaviours among prisoners in Kyrgyzstan and Azerbaijan: results from a nationally representative cross-sectional study.
Polonsky M; Azbel L; Wegman MP; Izenberg JM; Bachireddy C; Wickersham JA; Dvoriak S; Altice FL
J Int AIDS Soc; 2016; 19(4 Suppl 3):20880. PubMed ID: 27435715
[TBL] [Abstract][Full Text] [Related]
15. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.
Zamani S; Farnia M; Torknejad A; Alaei BA; Gholizadeh M; Kasraee F; Ono-Kihara M; Oba K; Kihara M
J Urban Health; 2010 Jul; 87(4):603-16. PubMed ID: 20390391
[TBL] [Abstract][Full Text] [Related]
16. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
[TBL] [Abstract][Full Text] [Related]
17. Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.
Polonsky M; Rozanova J; Azbel L; Bachireddy C; Izenberg J; Kiriazova T; Dvoryak S; Altice FL
AIDS Behav; 2016 Dec; 20(12):2950-2960. PubMed ID: 27011378
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
19. Risky behaviors for HIV infection among male incarcerated injection drug users in Taiwan: a case-control study.
Chen CH; Ko WC; Lee HC; Hsu KL; Ko NY
AIDS Care; 2008 Nov; 20(10):1251-7. PubMed ID: 19012084
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
